{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:06Z","timestamp":1786991466006,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.japh.2018.04.035","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T11:27:54Z","timestamp":1531308474000},"page":"S24-S29.e2","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S","title":["Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy"],"prefix":"10.1016","volume":"58","author":[{"given":"Emanuela V.","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Hamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonna L.","family":"Farinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Ricchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2018.04.035_bib1","series-title":"Diagnostic and Statistical Manual of\u00a0Mental Disorders","first-page":"87","author":"American Psychiatric Association. Schizophrenia spectrum and other psychotic disorders","year":"2013"},{"key":"10.1016\/j.japh.2018.04.035_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1016\/j.japh.2018.04.035_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.japh.2018.04.035_bib4","series-title":"Diagnostic and Statistical Manual of\u00a0Mental Disorders","first-page":"123","author":"American Psychiatric Association. Bipolar and related disorders","year":"2013"},{"issue":"6","key":"10.1016\/j.japh.2018.04.035_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4088\/JCP.15m10278","article-title":"The economic burden of schizophrenia in the United States in 2013","volume":"77","author":"Cloutier","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.japh.2018.04.035_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.2013.13805","article-title":"The state of US health, 1990-2010: burden of diseases, injuries, and risk factors","volume":"310","author":"Murray","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2018.04.035_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/PPA.S2940","article-title":"Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia","volume":"2","author":"Ascher-Svanum","year":"2008","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"10.1016\/j.japh.2018.04.035_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.japh.2018.04.035_bib9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1185\/030079907X226050","article-title":"Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States","volume":"23","author":"Sun","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.japh.2018.04.035_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2146\/ajhp080374","article-title":"Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge","volume":"66","author":"Hassan","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.japh.2018.04.035_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11414-013-9329-z","article-title":"Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophrenia","volume":"40","author":"Lin","year":"2013","journal-title":"J\u00a0Behav Health Serv Res"},{"key":"10.1016\/j.japh.2018.04.035_bib12","first-page":"1","article-title":"Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder","volume":"29","author":"Greene","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.japh.2018.04.035_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2045125314540297","article-title":"The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal","volume":"4","author":"Brissos","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"issue":"4","key":"10.1016\/j.japh.2018.04.035_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40801-015-0043-4","article-title":"Costs and resource utilization among Medicaid patients with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics","volume":"2","author":"Pesa","year":"2015","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"10.1016\/j.japh.2018.04.035_bib15","first-page":"357","article-title":"Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics","volume":"18","author":"Baser","year":"2015","journal-title":"J\u00a0Med Econ"},{"issue":"6","key":"10.1016\/j.japh.2018.04.035_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jpsychires.2012.02.019","article-title":"A\u00a0cost-consequence analysis of long-acting injectable risperidone in schizophrenia: a one-year mirror-image study with national claim-based database in Taiwan","volume":"46","author":"Chang","year":"2012","journal-title":"J\u00a0Psychiatr Res"},{"issue":"7","key":"10.1016\/j.japh.2018.04.035_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1037\/0003-066X.59.7.614","article-title":"How stigma interferes with mental health care","volume":"59","author":"Corrigan","year":"2004","journal-title":"Am Psychol"},{"issue":"9592","key":"10.1016\/j.japh.2018.04.035_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(07)61241-0","article-title":"Mental health systems in countries: Where are we now?","volume":"370","author":"Jacob","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.japh.2018.04.035_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/070674370905401106","article-title":"Negative attitudes toward help seeking for mental illness in 2 population-based surveys from the United States and Canada","volume":"54","author":"Jagdeo","year":"2009","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.japh.2018.04.035_bib20","series-title":"Mental Health: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"1999"},{"key":"10.1016\/j.japh.2018.04.035_bib21","series-title":"World Health Report 2001. Mental Health: New Understanding, New Hope","author":"World Health Organization","year":"2001"},{"issue":"3","key":"10.1016\/j.japh.2018.04.035_bib22","first-page":"214","article-title":"Access to rural mental health services: service use and out-of-pocket costs","volume":"26","author":"Ziller","year":"2010","journal-title":"J\u00a0Rural Health"},{"issue":"4","key":"10.1016\/j.japh.2018.04.035_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.japh.2017.04.001","article-title":"Report of the APhA Stakeholder Conference on Improving Patient Access to Injectable Medications","volume":"57","author":"Skelton","year":"2017","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2018.04.035_bib24","author":"American Pharmacists Association"},{"issue":"4","key":"10.1016\/j.japh.2018.04.035_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/0019-5545.104817","article-title":"A\u00a0study on patient satisfaction with psychiatric services","volume":"54","author":"Holikatti","year":"2012","journal-title":"Indian J Psychiatry"},{"issue":"6","key":"10.1016\/j.japh.2018.04.035_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YIC.0000000000000093","article-title":"Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics","volume":"30","author":"Kwon","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.japh.2018.04.035_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","article-title":"The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome","volume":"5","author":"Attkisson","year":"1982","journal-title":"Eval Program Plann"},{"issue":"20","key":"10.1016\/j.japh.2018.04.035_bib28","first-page":"619","article-title":"Attitudes toward mental illness\u201335 states, District of Columbia, and Puerto Rico, 2007","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2018.04.035_bib29","author":"National Alliance of State Pharmacy Associations"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911830219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911830219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T17:27:47Z","timestamp":1533403667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431911830219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S154431911830219X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2018.04.035","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}